Unsung Heroes

Unsung heroes are my very favorite kind. Whenever I read about an ordinary person (you know, the kind with family and job and so on) who does something special for someone else, I am inspired. And Karrie Munkittrick inspires me. I read about her recently in a LLS periodical and thought you might like to know more about her.

Who knows, maybe it will inspire you to do something bold.
She was an artist, wife and mother of two healthy daughters when leukemia struck her two-month old nephew, Austin. She became involved in the LLS Light The Night Walk, becoming a team captain, getting people to join the "Austin's Warriors" Light The Night team.. As a team captain, she raised funds herself and acted as a rallying force, urging on her team, which raised more than $6,300 in 2009!

This year, she found another way to help. As her husband Michael explains, "She's been a light to so many people and it has changed her. Now she wants to go where few people would ever consider going." Karrie is very pretty, both inside and out, and has long, beautiful hair. She decided to shave her head as a participant in LLS's Totally Baldacious campaign, in which people raise funds by shaving their heads to show support and solidarity for patients who lose their hair during cancer treatments.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap